HELICON
Live / Registered — Registered (as of 14 Nov 2023)
What this means for you
Registered since 14 Nov 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88693700
- Registration number
- 7219023
- Mark type
- Stylized text
- Filed
- 15 Nov 2019
- Published for opposition
- 23 Jun 2020
- Registered
- 14 Nov 2023
- Attorney of record
- Steven A. Abreu
Goods and services
- Class 005 — Pharmaceuticals: Biomedical compounds for medical purposes, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for the treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
Owner
- PARABILIS MEDICINES, INC., CAMBRIDGE, MA, US
- Fog Pharmaceuticals, Inc., Cambridge, MA, US
- Fog Pharmaceuticals, Inc., Cambridge, MA, US
- Fog Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 19 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Nov 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Nov 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Nov 2023 — REGISTERED-PRINCIPAL REGISTER
- 13 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Oct 2023 — EXAMINER'S AMENDMENT ENTERED
- 12 Oct 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Oct 2023 — EXAMINERS AMENDMENT E-MAILED
- 12 Oct 2023 — SU-EXAMINER'S AMENDMENT WRITTEN
- 23 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Aug 2023 — NON-FINAL ACTION E-MAILED
- 23 Aug 2023 — SU - NON-FINAL ACTION - WRITTEN